Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 7/20 | 0.52 |
| ▸ | MMP8 | P22894 | 3/20 | 0.52 |
| ▸ | MMP2 | P08253 | 11/20 | 0.51 |
| ▸ | MMP3 | P08254 | 5/20 | 0.51 |
| ▸ | MME | P08473 | 1/20 | 0.50 |
| ▸ | FCER2 | P06734 | 1/20 | 0.50 |
| ▸ | GNPAT | O15228 | 1/20 | 0.48 |
| ▸ | CTSS | P25774 | 1/20 | 0.48 |
| ▸ | CTSK | P43235 | 1/20 | 0.48 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.47 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.47 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.47 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.47 |
| ▸ | MMP9 | P14780 | 2/20 | 0.46 |
| ▸ | MMP7 | P09237 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13402948 | 0.91 | MMP1 (0.51) | MMP1MMP8MMP2MMP3MME | |
| SCHEMBL12918089 | 0.89 | MMP2 (0.47) | MMP1MMP8MMP2MMP3MME | |
| SCHEMBL27267618 | 0.89 | MME (0.53) | MMP1MMP8MMP2MMP3MME | |
| SCHEMBL15145509 | 0.89 | MME (0.53) | MMP1MMP8MMP2MMP3MME | |
| SCHEMBL13402940 | 0.88 | MMP1 (0.54) | MMP1MMP8MMP2MMP3MME | |
| SCHEMBL25380959 | 0.87 | MME (0.60) | MMP2MMEMMP9MMP7 | |
| SCHEMBL9181909 | 0.87 | MME (0.60) | MMP2MMEMMP9MMP7 | |
| SCHEMBL29311869 | 0.87 | MMP1 (0.50) | MMP1MMP8MMP2MMP3MME | |
| SCHEMBL17399495 | 0.85 | MME (0.54) | MMP1MMP2MMP3MMEGNPAT | |
| SCHEMBL27267988 | 0.85 | NPC1 (0.56) | MMP1MMP8MMP2MME |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240228671-A1 | POLYPEPTIDYL LINKERS | Quantum-Si Incorporated (US) | 2024-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240228671-A1 | POLYPEPTIDYL LINKERS | VIP, DNPEP, PREP | MMP1 262/4885MMP8 378/4885MMP2 80/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.